Large pharma companies at Cell 2026

Nov 12–13, 2026 London, UK ~800 attendees Website

6 large pharma companies are at Cell 2026 — 19 presentations on the program. Most represented: Bristol Myers Squibb (5 on the program), AstraZeneca (4 on the program), Johnson & Johnson (1 on the program). 3 of them have their own page in this guide. As of Oct 8, 2026.

All 109 organizations at Cell 2026 →

Showing 1–6 of 6 organizations

Organization	Cell 2026 Attendance
Bristol Myers Squibb Princeton, New Jersey
bms.com Large pharma Global drugmaker with marketed CAR-T cell therapies alongside medicines for cancer, immunology and cardiovascular disease.	Talk Thu Nov 12 9:25am–9:50am Advanced Technologies Driving The Next Wave Of Gene Therapy Cell and gene therapy Talk Thu Nov 12 10:15am–10:40am Phase Appropriate Analytical Strategies Including Comparability Analytics and characterizationManufacturing and CMC Panel Thu Nov 12 2:40pm–3:05pm Quality Control Strategies In Advanced CGTs with Quell Therapeutics, University of Liverpool Cell and gene therapyAnalytics and characterization Panel Thu Nov 12 2:40pm–3:05pm Where Does Big Pharma Stand In CGTs – And What Comes Next? with Johnson & Johnson, AstraZeneca Cell and gene therapy Talk Thu Nov 12 4:55pm–5:20pm From Vision And Concepts To Practical Execution - An Analytical Strategy And Lifecycle Execution Roadmap To Support Commercial Readiness And Operational Execution Success Analytics and characterizationManufacturing and CMC Talk Thu Nov 12 5:20pm–5:45pm One Lot, One Life: Scaling Hope for Patients with Autologous CART Treatments Cell and gene therapyManufacturing and CMC Talk Fri Nov 13 1:55pm–2:20pm Designing An End-To-End Supply Chain For CGTs Cell and gene therapyManufacturing and CMC
AstraZeneca Cambridge, UK
astrazeneca.com Large pharma Global drugmaker with medicines in oncology, cardiovascular, respiratory, immunology and rare disease, and a cell therapy pipeline.	Panel Thu Nov 12 12:25pm–12:50pm Cracking In Vivo Delivery For Next-Generation Gene Therapies with University Medical Center Freiburg, SymphoRNA, AviadoBio Cell and gene therapy Panel Thu Nov 12 12:25pm–12:50pm The Productivity Challenge: How Can The Industry Deliver More Medicines With Less with UCB Manufacturing and CMC Panel Thu Nov 12 2:40pm–3:05pm Where Does Big Pharma Stand In CGTs – And What Comes Next? with Bristol Myers Squibb, Johnson & Johnson Cell and gene therapy Talk Thu Nov 12 3:05pm–3:30pm Mapping Immune Vulnerabilities: CRISPR Screens for Target Discovery Stem cells, organoids and cell models Talk Fri Nov 13 3:10pm–3:35pm Cell Line Database Development Cell line developmentDigital biomanufacturing and AI Talk Fri Nov 13 3:50pm–4:15pm Clinical Trial Designs For Advanced Therapies Outside Of Oncology Cell and gene therapy Talk Fri Nov 13 4:15pm–4:40pm Reduction Of Animal Bi-Products In Cell Cultures Cell culture and upstream processing
Johnson & Johnson New Brunswick, New Jersey
jnj.com Large pharma Healthcare group whose Innovative Medicine arm, formerly Janssen, markets drugs including a CAR-T cell therapy for multiple myeloma.	Panel Thu Nov 12 2:40pm–3:05pm Where Does Big Pharma Stand In CGTs – And What Comes Next? with Bristol Myers Squibb, AstraZeneca Cell and gene therapy Panel Thu Nov 12 4:55pm–5:20pm Overcoming Hurdles With Global Commercialisation
Bayer Leverkusen, Germany
bayer.com Large pharma Pharmaceutical and crop science group whose cell and gene therapy work includes BlueRock Therapeutics and AskBio.	Talk Thu Nov 12 12:25pm–12:50pm Outsourcing Biologics’ CMC Development And Manufacturing – Considerations For Supplier Selection Manufacturing and CMC
Sanofi Paris, France
sanofi.com Large pharma Global drugmaker with vaccines and medicines for immunology, rare diseases, neurology and oncology.	Talk Thu Nov 12 10:15am–10:40am Digital Twin Modelling For Accelerating Technical Transfer For Upstream Processes & As Digital Shadows In Commercial Manufacturing Digital biomanufacturing and AICell culture and upstream processing
UCB Brussels, Belgium
ucb.com Large pharma Belgian biopharmaceutical company developing antibody and small-molecule medicines for immunology and neurology diseases.	Panel Thu Nov 12 12:25pm–12:50pm The Productivity Challenge: How Can The Industry Deliver More Medicines With Less with AstraZeneca Manufacturing and CMC